Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Summary
- Sadia Shah MD, MBA, FCCP is a Consultant Lung Transplant Pulmonologist and Critical Care Specialist with Mayo Clinic, Florida, specializing in treating patients with Lung Transplant acute cellular rejection, Antibody mediated rejection, Bronchiolitis Obliterans, Lung Transplant infection, Pulmonary Fibrosis, Interstitial Lung Disease secondary to connective tissue disease and Hypersensitivity Pneumonitis.
She served as the Medical Director for Larynx-Trachea Transplant Program as well as Interim Medical Director for Lung Transplant Program at Mayo Clinic, Arizona.
Dr. Shah is recognized for leading the Project that performed the first simultaneous CABG and bilateral lung transplant in the world at Mayo Clinic and for initiating the Lung Transplant for COVID disease Program.
She was Member, Mayo Clinic/Google Advisory Board. Member, Mayo Clinic 2030 Business Strategy Committee. Member, Mayo Clinic Transplant Leadership. Member, Lung Transplant Convergence Group. Member, Mayo Pharmaceutical Formulary Committee. Member, Transplant Quality Committee.
She is recipient of MEGA Award: Tracheal Replacement Using Bioengineered 3-D-Printed Tracheal Scaffold with Amniotic Membrane Inlay Graft.
Dr. Shah completed her Fellowship in Heart-Lung and Lung Transplant from Stanford University.
She is Board Certified in Pulmonary and Critical Care Medicine specializing in Lung Transplant medicine, Advanced Lung Diseases, Bronchoscopy, ….
Dr. Shah is Fellow College of Chest Physicians and an MBA, Summa cum Laude, Isenberg School of Management, University of Massachusetts.
Dr. Shah has been recognized as an esteemed educator teaching at Mayo Clinic Medical School for the past eight years. The research interests of Sadia Shah, M.D., are in Interstitial Lung Disease, Lung Transplant and Larynx-Trachea Transplant.
Clinical Expertise
- Transplant pulmonology, Critical care medicine, Interstitial lung disease, Cystic fibrosis, Interventional pulmonology, Chronic obstructive pulmonary disease, Pulmonary vascular disease, Lung transplantation, General pulmonology, Sarcoidosis, Sjogren's syndrome, Endobronchial ultrasonography, Central venous catheter placement
Education & Training
- MBA Summa Cum Laude, Isenberg School of Management, UMassMBA, Healthcare Management, Summa cum Laude, 2017 - 2019
- Kellogg School of Management at Northwestern UniversityAmerican Society of Transplant Surgeons Advanced Leadership Development Program, Strategic Management, 2017 - 2017
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Advanced Heart Failure and Transplant Cardiology, 2014 - 2015
- Henry Ford Health/Henry Ford HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2013
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2008 - 2011
- Dartmouth Hitchcock Medical CenterCertification, Cardiovascular disease, 2008 - 2008
- Harvard Medical SchoolCertification, Emergency Medicine, 2007 - 2007
- Isra UniversityClass of 2004
Certifications & Licensure
- AZ State Medical License 2017 - 2026
- CA State Medical License 2014 - 2026
- FL State Medical License 2017 - 2026
- GA State Medical License 2024 - 2026
- IL State Medical License 2015 - 2026
- MN State Medical License 2017 - 2026
- SC State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- United Network for Organ SharingLung Transplantation
- Join now to see all
Awards, Honors, & Recognition
- Top Pulmonologist Top Doctor, 2022
- Member, Mayo Clinic/Google Advisory Board Mayo Clinic/Google, 2019-2020
- Member, Mayo Clinic 2030 Business Strategy Committee Mayo Clinic, 2019
- Join now to see all
Publications & Presentations
PubMed
- Survival Outcomes of Lung Transplant Recipients From Donors With Abnormal Kidney Function.Magdy M El-Sayed Ahmed, Sadia Z Shah, Nan Zhang, Tambi Jarmi, Samuel Jacob
The Annals of Thoracic Surgery. 2023-11-01 - 1 citationsExpanded extracorporeal membrane oxygenation bridge to heart and lung transplant candidate selection does not impact outcomes compared to traditional candidate selecti...Abdul Wahab, Andrew C Hanson, Steve Peters, Mauricio A Villavicencio, Sahar A Saddoughi
Journal of Thoracic Disease. 2023-06-30 - 1 citationsCoronavirus Disease 2019 Causing Infection of Transplanted Lung Allograft: A Pitfall of Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus-2 Pretransp...Sadia Z Shah, Francisco G Alvarez, Devang K Sanghavi, Pablo Moreno Franco, Shahin Isha
Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2023-04-01
Journal Articles
- Comparison of Outcomes from Sepsis between Patients with and without Pre-existing Left Ventricular Dysfunction : a Case-Control AnalysisShah, S; Ouellette, D, Critical Care, 1/1/2014
- Basiliximab induced non-cardiogenic pulmonary edema After Renal TransplantShah, S; Thavarajah, K, American Thoracic Society (ATS), 1/1/2014
- A sporadic case of benign recurrent intrahepatic cholestasis (Summerskill-Walshe- Tygstrug syndrome) with an unusual presentationZalawadia, A., Sheth, M., Vlahakis, S, American College of Physicians (ACP), 1/1/2009
- Join now to see all
Abstracts/Posters
- Immunosuppression for Lung Transplantation: Current and FutureSatish Chandrashekaran;Stacy A. Crow;Sadia Z. Shah;Chris J. Arendt;Cassie C. Kennedy, Thoracic Transplantation, 7/13/2018
- Donation after circulatory death and lung transplantation for cystic fibrosisKirkby SE, Hayes D Jr., Whitosn B, Pope-Harman A, Keller B, Tobias JD, Tumin D, Pediatr Pulmonol, 1/1/2016
- Early Goal-Directed Therapy for Sepsis in Patients with Preexisting Left Ventricular Dysfunction: A Retrospective Comparison of Outcomes Based Upon Protocol AdherenceShah, S; Ouellette, D, CHEST, 1/1/2010
- Join now to see all
Lectures
- Utility of six-minute-walk-distance benefit area in the lung allocation score era1/1/2016
- Use of Anti- Tumor Necrosis Factor Alpha Therapy for Treatment of Post- Lung Transplant Recurrent Sarcoidosis: A Case Series1/1/2014
- Early recurrence of Endobronchial Sarcoidsis post Lung Transplant successfully treated with Anti-Tumor Necrosis Factor alpha Blockade1/1/2013
Press Mentions
- COVID-19 Vaccines May Not Be Effective for Organ Transplant Patients, Research SuggestsApril 26th, 2021
- Covid-19 : COVID-19 Leaves Long-Lasting ComplicationsJanuary 30th, 2021
- Some Signs of Recovery from Severe Covid Lung DamageOctober 18th, 2020
Committees
- Member, Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2018 - Present
- Member, Mayo Clinic: ARZ Plummer Provider Advocate Forum 2018 - Present
- Member, Mayo Clinic: Enterprise Transplant Center, Lung Convergence Group 2018 - Present
- Member, Mayo Clinic Transplant Research Committee 2018 - Present
- Member, Mayo Clinic - Pharmaceutical Formulary Committee 2018 - Present
- Super User, Mayo Clinic -Plummer Project EPIC 2018 - Present
- Member, Mayo Clinic - Transplant Center Quality Committee 2018 - Present
- Member, Mayo Clinic -Greater Leadership Opportunities for Women (GLOW) 2018 - Present
- Member, Mayo Clinic - Quality and Process Improvement Committee 2018 - Present
Professional Memberships
- Member
- Member
- Member
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: